NCT06932731 Mind-Body Intervention for Older Adults in Long-term Care
| NCT ID | NCT06932731 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Long Term Care Facility |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-04-17 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-04-17 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Loneliness is a global health issue, particularly affecting the physical and mental health of older adults residing in long term care. The COVID-19 pandemic has further exacerbated isolation in these settings, calling for an urgent attention for finding an effective intervention to alleviate loneliness among long term care residents. Mind-body interventions (MBIs) present as a potentially promising approach aimed at reducing loneliness and mental wellbeing. This study aims to examine the effect of a nurse-led MBI compared to a befriending intervention on loneliness, quality of life, depression and level of mindfulness among older adults in long term care. The primary outcome is loneliness while secondary outcome is quality of life, depression and level of mindfulness.
Eligibility Criteria
Inclusion Criteria: * Long-term care residents aged 60 or above * Communicable in Cantonese/Chinese * Mentally competent (Abbreviated Mental Test score \>6) * Could read, write and understand Chinese language * Able to provide written consent Exclusion Criteria: * Have regular practice of mindfulness once a week or more during the past 6 months * Have any other contraindication or severe comorbidity that may limit their full participation (e.g. acute psychiatric conditions, severe hearing, vision impairment, or severe medical condition etc).
Contact & Investigator
Jojo Yan Yan Kwok, PhD
PRINCIPAL INVESTIGATOR
The University of Hong Kong
Frequently Asked Questions
Who can join the NCT06932731 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Long Term Care Facility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06932731 currently recruiting?
Yes, NCT06932731 is actively recruiting participants. Contact the research team at jodies@connect.hku.hk for enrollment information.
Where is the NCT06932731 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong, Hong Kong, Hong Kong.
Who is sponsoring the NCT06932731 clinical trial?
NCT06932731 is sponsored by The University of Hong Kong. The principal investigator is Jojo Yan Yan Kwok, PhD at The University of Hong Kong. The trial plans to enroll 120 participants.